Product Details
| Product Name:
GDC-0927 |
CAS No.:
1642297-01-5 |
| Supply Ability:
10g |
Release date:
2025/10/27 |
Product Introduction
Bioactivity
| Name | GDC-0927 |
| Description | GDC-0927 is a novel,non-steroidal, potent, orally bioavailable, selective estrogen receptor antagonist. |
| In vivo | GDC-0927, a novel and potent non-steroidal, orally bioavailable selective estrogen receptor (ER) antagonist/degrader (SERD), effectively induces tumor regression in patient-derived xenograft models of estrogen receptor-positive (ER+) breast cancer (BC). |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 83.33 mg/mL (180.56 mM), Sonication is recommended.
|
| Keywords | SRN927 | SRN 927 | GDC-0927 | GDC0927 | GDC 0927 | Estrogen receptor |
| Inhibitors Related | Tamoxifen | Kaempferol | 2-Ethylhexyl trans-4-methoxycinnamate | Estradiol benzoate | ARV-471 | Bisphenol B | Octinoxate | Mequinol | Chlorothalonil | Chrysin | Ethisterone | Cholesterol |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:1428569-85-0
$0.00 / 25mg
-
CAS:1494581-70-2
$987.00 / 25mg
-
CAS:1133432-49-1
$198.00 / 2mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$87.00/5mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-11-10 |
|
|
$0.00/5mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-08-21 |
|
|
$1.10/1g |
VIP5Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2021-05-08 |
United States